Home Home > Browse Locations > Russian Federation

Find Paid Clinical Trials in Russia

Paid Clinical Trials and Focus Groups


Paid Clinical Trials in Russian Federation

Top of Directory » All Locations » Russian Federation


  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Glycopyrronium bromide;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified October 2009

  • Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: NN1250;   Drug: NN1250;   Drug: insulin glargine
    Sponsor:   Novo Nordisk
    Not yet recruiting - verified September 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • Aripiprazole Open-Label Rollover Study

    Condition:   Schizophrenia
    Intervention:   Drug: Aripiprazole
    Sponsor:   Otsuka Pharmaceutical Development & Commercialization, Inc.
    Active, not recruiting - verified October 2009

  • Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome

    Condition:   Acute Coronary Syndrome
    Intervention:   Drug: Lornoxicam
    Sponsor:   Central Clinical Hospital of the Presidential Administration of the Russian Federation
    Completed - verified October 2009

  • A Study of Tocilizumab Added to Disease-modifying Antirheumatic Drugs (DMARDs) in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: DMARDs (disease-modifying antirheumatic drugs)
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified October 2009

  • Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes

    Condition:   Acute Coronary Syndrome
    Interventions:   Drug: YM150;   Drug: Placebo
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified October 2009

  • Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

    Condition:   Arrhythmia Prophylaxis
    Interventions:   Drug: Celivarone (SSR149744);   Drug: amiodarone;   Drug: placebo
    Sponsor:   Sanofi-Aventis
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials